# The Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2013, Article 4: Amendment to the Misuse of Drugs (Designation) Order (Northern Ireland) 2001


After paragraph 3 of Part II of the Schedule (which specifies controlled drugs excepted from Part I) insert—
“4. A liquid formulation—
(a) containing a botanical extract of cannabis—
(i) with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and
(ii) where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,
(b) which is dispensed through a metered dose pump as a mucosal mouth spray, and
(c) which was approved for marketing by the Medicines and Healthcare products Regulatory Agency on 16th June 2010”

---
Source: https://www.legislation.gov.uk/nisr/2013/77/article/4 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-designation-amendment-order-northern-ireland-2013/article-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.